Albacia, Analiza T.

HRN: 23-48-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
CEFUROXIME 1.5GM (VIAL)
09/02/2023
09/03/2023
IV
1.5g
Q8h
S/p Primary LTCS
Waiting Final Action 
09/08/2023
CEFUROXIME 500MG (TAB)
09/08/2023
09/14/2023
P0
1 Tab
BID
Post CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: